Fed. Circ. Axes Bayer ED Drug Patent, Reversing Lower Court
The Federal Circuit ruled Wednesday that a Bayer patent on the erectile dysfunction drug Staxyn is invalid as obvious, handing a win to generics maker Teva with a strongly worded finding...To view the full article, register now.
Already a subscriber? Click here to view full article